Amgen Denosumab Drug Helps Prevent Bone Loss

July 15, 2008

According to the drug manufacturer Amgen, a drug of theirs known as denosumab has the ability to prevent bone loss..Washington (ChattahBox) – According to the drug manufacturer Amgen, a drug of theirs known as denosumab has the ability to prevent bone loss.

Amgen conducted a trial which included 1,400 prostate cancer patients.

They found after the trial that the drug was able to prevent bone loss, reducing the risk of osteoporosis in the men who took part.

The men who received the drug also had a reduced risk of new vertebral fractures, compared to the men who received a placebo.

Amgen has exclaimed their excitement over these results, and now looks to a study called FREEDOM to further find how the drug prevents bone loss.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.